Product Information

FROVATRIPTAN SUCC 2.5 MG TAB is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $2.6965 per EA under NDC 50742029909. Its NADAC has been published 206 times since Dec 7, 2022.

FDA first approved this application on Apr 6, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FROVATRIPTAN SUCC 2.5 MG TAB

frovatriptan succinate
$2.6965per EA

Strength

2.5 mg/1

NDC

50742029909

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

FROVATRIPTAN SUCCINATE

Approval Type

Generic (ANDA)

FDA Application

ANDA213891

FDA Approved

4/6/2022

TE Code

AB

On Market Since

7/22/2022

Pharmacological Classes

Serotonin 1b Receptor Agonists
Serotonin 1d Receptor Agonists
Serotonin-1b and Serotonin-1d Receptor Agonist

Price Statistics

The NADAC for FROVATRIPTAN SUCC 2.5 MG TAB has been published 206 times since Dec 7, 2022, and over the history we have for it it has declined 67.7%. The table below summarizes its recorded NADAC range and movement.

Current price$2.6965 per EA
All-time high$12.1187 (Aug 16, 2023)
All-time low$2.6965 (Oct 21, 2026)
52-week high$3.5805
52-week low$2.6965
Median price$4.2409
Average price$5.4872
Largest weekly change+77.7% (Jun 19, 2024)
Weeks tracked206
Tracking sinceDec 7, 2022

Price History

1W

0.0%

1M

-0.8%

3M

-3.0%

6M

-16.6%

1Y

-25.6%

3Y

-64.4%

5Y

N/A

All

-67.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FROVATRIPTAN SUCC 2.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for FROVATRIPTAN SUCC 2.5 MG TAB, manufactured by Ingenus Pharmaceuticals LLC, is $2.6965 per EA (NDC 50742029909), effective Nov 11, 2026.

How has the price of FROVATRIPTAN SUCC 2.5 MG TAB changed over time?

Over the history we have for it, the NADAC for FROVATRIPTAN SUCC 2.5 MG TAB has declined 67.7%. It has been tracked across 206 weekly CMS publications since Dec 7, 2022.

What are the highest and lowest recorded NADAC prices for FROVATRIPTAN SUCC 2.5 MG TAB?

Since Dec 7, 2022, the NADAC for FROVATRIPTAN SUCC 2.5 MG TAB has ranged from a low of $2.6965 (Oct 21, 2026) to a high of $12.1187 (Aug 16, 2023), with a median of $4.2409 per EA.

Are there cheaper alternatives to FROVATRIPTAN SUCC 2.5 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FROVATRIPTAN SUCC 2.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures FROVATRIPTAN SUCC 2.5 MG TAB?

FROVATRIPTAN SUCC 2.5 MG TAB (NDC 50742029909) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.